PuSH - Publication Server of Helmholtz Zentrum München

Bornstein, S.R. ; Rubino, F.* ; Khunti, K.* ; Mingrone, G.* ; Hopkins, D.* ; Birkenfeld, A.L. ; Boehm, B.* ; Amiel, S.* ; Holt, R.I.* ; Skyler, J.S.* ; deVries, J.H.* ; Renard, E.* ; Eckel, R.H.* ; Zimmet, P.* ; Alberti, K.G.* ; Vidal, J.* ; Geloneze, B.* ; Ludwig, B.

Practical recommendations for the management of diabetes in patients with COVID-19.

Lancet Diabet. Endocrinol. 8, 546-550 (2020)
DOI Order publishers version
Open Access Green as soon as Postprint is submitted to ZB.
Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20-50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Keywords Coronavirus; Receptor
ISSN (print) / ISBN 2213-8587
e-ISSN 2213-8595
Quellenangaben Volume: 8, Issue: 6, Pages: 546-550 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Reviewing status Peer reviewed
Institute(s) Institute for Pancreatic Beta Cell Research (IPI)
Institute of Diabetes Research and Metabolic Diseases (IDM)